Clinical studies have demonstrated significant improvements in glucose control when Pendulum products are used alongside traditional diabetes treatments, suggesting similar benefits may exist when combined with GLP-1s
In zeldzame gevallen kunnen andere klachten optreden, zoals duizeligheid
In obese patients, SEMA induced a 16% reduction in weight while RETA demonstrated substantial weight loss up to 24% 19,20
(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
Evidence standard FormBlends does not claim an individual clinician byline unless a named reviewer is available
The use of affiliate tracking links is disclosed in accordance with the Federal Trade Commissions guidelines for endorsements and testimonials in advertising (16 CFR Part 255)
